Sign In
Buy LEGN
$35.98
-0.300 (-0.83%)
At Close: Jun 03, 2026
Drug Startups Eye Quicker Profits Under China's New Fast-Track Approvals
02:01pm, Wednesday, 09'th Jun 2021
A recent regulatory overhaul designed to speed up development and approval of new drugs in China has been welcomed by global pharma giants and local startups alike, aimed at bringing their latest cutt
Moving Average Crossover Alert: Legend Biotech (LEGN)
07:31am, Friday, 04'th Jun 2021
Legend Biotech (LEGN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
LEGN Stock Price: Over 7% Increase Pre-Market Explanation
08:29am, Tuesday, 01'st Jun 2021
The stock price of Legend Biotech Corp (NASDAQ: LEGN) increased by over 7% pre-market. This is why it happened.
U.S. Food and Drug Administration Grants BCMA CAR-T Cilta-cel Priority Review for the Treatment for Relapsed/Refractory Multiple Myeloma
05:11pm, Wednesday, 26'th May 2021
SOMERSET, N.J.--(BUSINESS WIRE)---- $LEGN #CARTcell--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and developm
Legend Biotech to Present at the Jefferies Virtual Healthcare Conference
09:30am, Tuesday, 25'th May 2021
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
Are Options Traders Betting on a Big Move in Legend Biotech (LEGN) Stock?
09:46am, Thursday, 20'th May 2021
Investors need to pay close attention to Legend Biotech (LEGN) stock based on the movements in the options market lately.
Legend Biotech (LEGN) Stock: Over 10% Increase Explanation
02:56pm, Tuesday, 18'th May 2021
The stock price of Legend Biotech Corp (NASDAQ: LEGN) increased by over 10% during intraday trading. This is why it happened.
Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse
02:52pm, Sunday, 16'th May 2021
Genscript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to Genscript's Legend Biotech CAR-T subsidiary. Shanghai Fosun Pharma
Legend Biotech (LEGN) Stock: Over 10% Increase Pre-Market Explanation
07:32am, Friday, 14'th May 2021
The stock price of Legend Biotech Corp (NASDAQ: LEGN) increased by over 10% pre-market. This is why it happened.
Legend Biotech Reports New and Updated Data from BCMA CAR-T Program at 2021 ASCO and EHA Meetings
12:11pm, Wednesday, 12'th May 2021
SOMERSET, N.J.--(BUSINESS WIRE)---- $LEGN #ASCO21--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and developmen
Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal
05:29pm, Monday, 03'rd May 2021
CANbridge will make a $10 million upfront payment for the two Fabry and Pompe candidates. Guangzhou Link Health Pharma and Australia's George Clinical plan to form a China clinical CRO JV that will co
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
Legend Biotech Corporation (LEGN) CEO Ying Huang on Q4 2020 Results - Earnings Call Transcript
09:43am, Thursday, 18'th Mar 2021
Legend Biotech Corporation (LEGN) CEO Ying Huang on Q4 2020 Results - Earnings Call Transcript
Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update
07:00am, Thursday, 18'th Mar 2021
SOMERSET, N.J.--(BUSINESS WIRE)---- $LEGN #biotech--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and developme
Legend Biotech Announces Fourth Quarter and Full-Year 2020 Earnings Conference Call
04:30pm, Wednesday, 10'th Mar 2021
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
